Eugenio Battaglia

Eugenio Battaglia

Oct 04, 2014

Group 6 Copy 70
0
    Please wait...

    About This Project

    BioPeers – Peers Center for Biotech and Society
    Our bodies produce very low doses of N,N-Dimethyltryptamine (DMT), a psychotropic substance. Recent findings suggest that DMT is an important modulator of Sig-1R, a receptor that plays important roles in neuropsychiatric diseases like schizophrenia, and depression. This project aims to further develop a hypothesis for the relation between DMT and Sig-1R, in hopes of providing novel insight into these neuropsychiatric diseases.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Developing a New Mouse Model for Studying Chemotherapeutic Nephrotoxicity

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute...

    Can Data Management Tools Improve Research Efficiency and Reproducibility?

    Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

    How does sleep deprivation impact problematic eating?

    Research studies have linked characteristics of eating disorders (e.g., binge eating, extreme dieting) with...

    Backer Badge Funded